Monoamine Oxidase Inhibitor [EPC]

Monoamine Oxidase Inhibitor [EPC] was reported 3094 times

Drugs of the Monoamine Oxidase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ADRENAL MEDULLA HYPERFUNCTION 1 1.0000
1 DYSKINESIA HYPERPYREXIA SYNDROME 25 0.5319
2 AEROPHOBIA 1 0.1250
3 PARKINSONISM HYPERPYREXIA SYNDROME 18 0.1006
4 NOTHING BY MOUTH ORDER 2 0.0909
5 MEDICAL AID IN DYING 2 0.0833
6 APPLICATION SITE HYPERTROPHY 1 0.0714
7 HERBAL TOXICITY 2 0.0667
8 CATECHOLAMINE CRISIS 2 0.0541
9 DOPAMINE DYSREGULATION SYNDROME 24 0.0538
10 PARKINSONIAN REST TREMOR 9 0.0476
11 HYPOSOMNIA 2 0.0435
12 PARKINSONIAN CRISIS 4 0.0388
13 KLEPTOMANIA 2 0.0274
14 JEALOUS DELUSION 7 0.0247
15 DYSACUSIS 3 0.0242
16 APPLICATION SITE URTICARIA 42 0.0187
17 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 7 0.0174
18 ACROPHOBIA 1 0.0167
19 APPLICATION SITE BRUISING 1 0.0164
20 HYPERSEXUALITY 28 0.0153
21 CAMPTOCORMIA 3 0.0125
22 ADRENERGIC SYNDROME 1 0.0123
23 NERVE CONDUCTION STUDIES ABNORMAL 2 0.0120
24 APPLICATION SITE MASS 3 0.0109
25 FALSE POSITIVE INVESTIGATION RESULT 11 0.0109
26 IMPULSE-CONTROL DISORDER 22 0.0107
27 CATHETER SITE NODULE 2 0.0105
28 APPLICATION SITE REACTION 73 0.0104
29 SPINAL EPIDURAL HAEMATOMA 6 0.0102
30 VOLVULUS OF SMALL BOWEL 2 0.0102
31 EXCESSIVE MASTURBATION 2 0.0097
32 PATHOLOGICAL GAMBLING 16 0.0096
33 PARKINSONIAN GAIT 6 0.0096
34 RAPID EYE MOVEMENTS SLEEP ABNORMAL 4 0.0094
35 APPLICATION SITE RASH 127 0.0092
36 URINE AMPHETAMINE POSITIVE 3 0.0091
37 SOFT TISSUE MASS 4 0.0087
38 FREEZING PHENOMENON 32 0.0086
39 RECALL PHENOMENON 7 0.0084
40 SOMATIC DELUSION 2 0.0081
41 APPLICATION SITE SCAR 10 0.0080
42 ADMINISTRATION SITE RASH 1 0.0078
43 DROPPED HEAD SYNDROME 3 0.0076
44 ASYMPTOMATIC BACTERIURIA 1 0.0074
45 APPLICATION SITE NODULE 1 0.0073
46 DEJA VU 2 0.0073
47 ON AND OFF PHENOMENON 39 0.0070
48 APPLICATION SITE ERYTHEMA 183 0.0070
49 BINOCULAR EYE MOVEMENT DISORDER 2 0.0069
50 REDUCED FACIAL EXPRESSION 7 0.0069
51 GAMBLING 8 0.0069
52 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 6 0.0067
53 NUCHAL RIGIDITY 6 0.0066
54 APPLICATION SITE INFLAMMATION 9 0.0065
55 APPLICATION SITE DERMATITIS 6 0.0064
56 STOMA SITE HYPERGRANULATION 4 0.0063
57 ECHOLALIA 2 0.0063
58 PHAEOCHROMOCYTOMA 4 0.0061
59 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 3 0.0060
60 HALLUCINATION, TACTILE 4 0.0060
61 SALIVA DISCOLOURATION 2 0.0060
62 APPLICATION SITE DISCOLOURATION 24 0.0059
63 APPLICATION SITE INDURATION 1 0.0059
64 STOMA SITE REACTION 4 0.0058
65 MARITAL PROBLEM 3 0.0056
66 GAMBLING DISORDER 15 0.0055
67 APPLICATION SITE HAEMATOMA 1 0.0055
68 BURNING MOUTH SYNDROME 3 0.0053
69 APPLICATION SITE PRURITUS 120 0.0053
70 APPLICATION SITE INJURY 1 0.0053
71 STOMA SITE EXTRAVASATION 2 0.0052
72 APPLICATION SITE IRRITATION 62 0.0050
73 DEEP BRAIN STIMULATION 3 0.0050
74 DEVICE COLOUR ISSUE 2 0.0050
75 APPLICATION SITE HYPERSENSITIVITY 6 0.0049
76 MASKED FACIES 2 0.0049
77 POTENTIATING DRUG INTERACTION 16 0.0048
78 CAROTID ARTERY DISSECTION 2 0.0047
79 APPLICATION SITE EROSION 6 0.0047
80 BINGE EATING 5 0.0046
81 NITRITE URINE PRESENT 2 0.0046
82 DELUSION OF GRANDEUR 2 0.0045
83 PLEUROTHOTONUS 4 0.0044
84 COMPULSIVE SHOPPING 9 0.0044
85 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 1 0.0043
86 DRUG SCREEN FALSE POSITIVE 12 0.0043
87 SEXUALLY INAPPROPRIATE BEHAVIOUR 2 0.0043
88 STOMA SITE ERYTHEMA 8 0.0043
89 HYPERTENSIVE EMERGENCY 5 0.0042
90 LABILE BLOOD PRESSURE 5 0.0042
91 SLEEP ATTACKS 2 0.0042
92 APPLICATION SITE VESICLES 27 0.0042
93 APPLICATION SITE BLEEDING 1 0.0040
94 NECROTISING OESOPHAGITIS 2 0.0040
95 MULTIPLE DRUG THERAPY 3 0.0040
96 OESOPHAGEAL ULCER HAEMORRHAGE 2 0.0039
97 SCAPULA FRACTURE 2 0.0038
98 MEDICAL DEVICE CHANGE 2 0.0038
99 COMPULSIVE SEXUAL BEHAVIOUR 3 0.0037
100 STOMA SITE DISCHARGE 10 0.0036
101 POSTNASAL DRIP 2 0.0036
102 HALLUCINATION, VISUAL 76 0.0036
103 PARKINSON'S DISEASE 9 0.0035
104 SLEEP TALKING 6 0.0035
105 CHOREA 6 0.0035
106 DYSKINESIA 141 0.0035
107 IMPULSIVE BEHAVIOUR 13 0.0035
108 ORTHOSTATIC HYPERTENSION 2 0.0034
109 FOOD INTERACTION 6 0.0034
110 AKINESIA 7 0.0034
111 APPLICATION SITE SWELLING 16 0.0032
112 ASOCIAL BEHAVIOUR 1 0.0031
113 RESTING TREMOR 2 0.0031
114 ANOREXIA NERVOSA 1 0.0031
115 HYPERMAGNESAEMIA 2 0.0031
116 COMPULSIONS 2 0.0030
117 ARRHYTHMIC STORM 1 0.0030
118 MITRAL VALVE STENOSIS 2 0.0030
119 LIBIDO INCREASED 6 0.0030
120 CHOREOATHETOSIS 2 0.0029
121 SEROTONIN SYNDROME 56 0.0029
122 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 2 0.0029
123 BRADYKINESIA 17 0.0029
124 HALLUCINATIONS, MIXED 12 0.0029
125 POSTURE ABNORMAL 9 0.0028
126 SYMPTOM MASKED 2 0.0027
127 DELUSIONAL DISORDER, UNSPECIFIED TYPE 2 0.0027
128 DELUSION 40 0.0026
129 APPLICATION SITE HAEMORRHAGE 7 0.0026
130 LABORATORY TEST INTERFERENCE 2 0.0025
131 MUSCLE RIGIDITY 29 0.0024
132 ILLUSION 4 0.0024
133 APPLICATION SITE LACERATION 1 0.0024
134 PERSECUTORY DELUSION 6 0.0024
135 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
136 CRANIOFACIAL FRACTURE 2 0.0023
137 STOMA SITE INFECTION 3 0.0023
138 THALAMUS HAEMORRHAGE 2 0.0023
139 HALLUCINATION 172 0.0023
140 EXTRADURAL HAEMATOMA 3 0.0023
141 SENSATION OF PRESSURE 2 0.0023
142 FACIAL PARESIS 8 0.0023
143 OBSESSIVE THOUGHTS 4 0.0022
144 FIBROMA 2 0.0022
145 SUDDEN ONSET OF SLEEP 3 0.0022
146 STEREOTYPY 2 0.0021
147 CATAPLEXY 3 0.0021
148 APPLICATION SITE BURN 10 0.0020
149 APPLICATION SITE INFECTION 1 0.0020
150 APPLICATION SITE EXFOLIATION 8 0.0019
151 LIVEDO RETICULARIS 4 0.0019
152 COGWHEEL RIGIDITY 2 0.0019
153 ORTHOSTATIC HYPOTENSION 33 0.0019
154 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
155 YAWNING 5 0.0019
156 DISINHIBITION 3 0.0019
157 NEUROLEPTIC MALIGNANT SYNDROME 22 0.0019
158 PRODUCT RESIDUE PRESENT 10 0.0019
159 HYPERPHAGIA 7 0.0018
160 APPLICATION SITE DISCHARGE 2 0.0017
161 APPLICATION SITE PAIN 38 0.0017
162 HYPORESPONSIVE TO STIMULI 2 0.0017
163 APPLICATION SITE DISCOMFORT 3 0.0017
164 SKIN MASS 11 0.0016
165 PARKINSONISM 16 0.0016
166 HYPOMANIA 6 0.0016
167 TESTICULAR SWELLING 2 0.0016
168 HOSTILITY 4 0.0016
169 SUBCUTANEOUS HAEMATOMA 2 0.0016
170 REHABILITATION THERAPY 6 0.0015
171 PANIC DISORDER 6 0.0015
172 NASAL SEPTUM DEVIATION 3 0.0015
173 ANISOCYTOSIS 1 0.0015
174 PRODUCT ADHESION ISSUE 54 0.0015
175 AGORAPHOBIA 2 0.0015
176 HYPERTENSIVE CRISIS 16 0.0014
177 DEVICE CONNECTION ISSUE 3 0.0014
178 APPLICATION SITE ULCER 1 0.0014
179 DERMATITIS CONTACT 16 0.0014
180 CEREBELLAR HAEMORRHAGE 2 0.0014
181 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
182 APALLIC SYNDROME 1 0.0014
183 MUTISM 2 0.0014
184 JUDGEMENT IMPAIRED 2 0.0014
185 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
186 BIPOLAR I DISORDER 3 0.0014
187 AORTIC VALVE SCLEROSIS 1 0.0014
188 STOMA SITE PAIN 2 0.0014
189 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
190 THERAPEUTIC PRODUCT EFFECT VARIABLE 5 0.0013
191 NONSPECIFIC REACTION 7 0.0013
192 INTESTINAL OPERATION 2 0.0013
193 DIABETES INSIPIDUS 3 0.0012
194 SHOULDER FRACTURE 2 0.0012
195 STRESS CARDIOMYOPATHY 7 0.0012
196 TONGUE ULCERATION 4 0.0012
197 APPLICATION SITE DRYNESS 4 0.0012
198 MOTOR DYSFUNCTION 12 0.0012
199 SEDATION COMPLICATION 3 0.0012
200 APTYALISM 1 0.0012
201 HYPOKINESIA 17 0.0012
202 CERVICAL VERTEBRAL FRACTURE 4 0.0012
203 WOUND INFECTION STAPHYLOCOCCAL 2 0.0012
204 THYROIDECTOMY 2 0.0012
205 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
206 TENSION 7 0.0011
207 DRUG SCREEN POSITIVE 9 0.0011
208 LOGORRHOEA 4 0.0011
209 PRODUCT CLEANING INADEQUATE 3 0.0011
210 AORTIC VALVE STENOSIS 2 0.0011
211 BRADYPNOEA 3 0.0011
212 PSYCHOMOTOR HYPERACTIVITY 18 0.0011
213 ALCOHOL USE 4 0.0011
214 LIVING IN RESIDENTIAL INSTITUTION 2 0.0011
215 NARCOLEPSY 2 0.0011
216 PARANOIA 18 0.0010
217 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
218 OESOPHAGEAL ULCER 4 0.0010
219 CONVERSION DISORDER 2 0.0010
220 APPLICATION SITE BRUISE 1 0.0010
221 ATROPHY 2 0.0010
222 DEVICE POWER SOURCE ISSUE 3 0.0010
223 DROOLING 7 0.0010
224 SMALL FOR DATES BABY 5 0.0010
225 ANTISOCIAL BEHAVIOUR 1 0.0010
226 NORMOCHROMIC NORMOCYTIC ANAEMIA 3 0.0010
227 PSYCHOTIC SYMPTOM 2 0.0010
228 CHEST INJURY 2 0.0010
229 INTENTIONAL UNDERDOSE 7 0.0010
230 DEVICE MATERIAL ISSUE 2 0.0010
231 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
232 DRUG EFFECT INCREASED 3 0.0009
233 DRUG EFFECT DECREASED 51 0.0009
234 TORTICOLLIS 2 0.0009
235 APPLICATION SITE PAPULES 1 0.0009
236 SCREAMING 6 0.0009
237 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
238 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
239 DYSTONIA 18 0.0009
240 REACTION TO DRUG EXCIPIENTS 2 0.0009
241 MANIA 15 0.0009
242 AORTIC DILATATION 1 0.0009
243 NIGHTMARE 31 0.0009
244 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
245 DRUG INTERACTION 139 0.0009
246 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
247 ABNORMAL DREAMS 24 0.0009
248 POLYMENORRHOEA 3 0.0009
249 ABNORMAL BEHAVIOUR 34 0.0009
250 DISTURBANCE IN SOCIAL BEHAVIOUR 2 0.0008
251 DECREASED INTEREST 5 0.0008
252 URINARY HESITATION 2 0.0008
253 WEIGHT ABNORMAL 2 0.0008
254 SELF ESTEEM DECREASED 2 0.0008
255 SLOW SPEECH 2 0.0008
256 BREATH ODOUR 2 0.0008
257 AGITATION 59 0.0008
258 INFREQUENT BOWEL MOVEMENTS 2 0.0008
259 PRE-EXISTING CONDITION IMPROVED 5 0.0008
260 VENTRICULAR HYPERTROPHY 2 0.0008
261 EXCORIATION 2 0.0008
262 ACIDOSIS 6 0.0008
263 APPLICATION SITE WARMTH 1 0.0008
264 THERAPEUTIC RESPONSE SHORTENED 26 0.0008
265 DEVICE OCCLUSION 11 0.0008
266 EUPHORIC MOOD 8 0.0008
267 GINGIVAL DISORDER 3 0.0008
268 ADJUSTMENT DISORDER 1 0.0008
269 CHOKING 15 0.0008
270 APPLICATION SITE PARAESTHESIA 1 0.0008
271 SEXUAL DYSFUNCTION 9 0.0008
272 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
273 WALKING AID USER 5 0.0008
274 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
275 CONFUSIONAL STATE 122 0.0008
276 CEREBRAL ATROPHY 3 0.0008
277 MIDDLE INSOMNIA 14 0.0007
278 AREFLEXIA 2 0.0007
279 GAIT INABILITY 25 0.0007
280 INSOMNIA 199 0.0007
281 DYSARTHRIA 28 0.0007
282 ENURESIS 3 0.0007
283 NOCTURIA 9 0.0007
284 TREMOR 123 0.0007
285 HIP SURGERY 4 0.0007
286 CLUMSINESS 2 0.0007
287 AKATHISIA 10 0.0007
288 TENOSYNOVITIS 2 0.0007
289 CHOLECYSTITIS INFECTIVE 2 0.0007
290 IRRITABILITY 43 0.0007
291 DRUG TOLERANCE DECREASED 2 0.0007
292 SKIN HYPERTROPHY 2 0.0007
293 PSYCHOTIC DISORDER 21 0.0007
294 EJACULATION DISORDER 2 0.0007
295 SUICIDAL IDEATION 64 0.0007
296 HYPOGLYCAEMIC COMA 2 0.0007
297 HAEMOTHORAX 2 0.0007
298 IMMOBILE 3 0.0007
299 GASTROINTESTINAL NECROSIS 2 0.0007
300 MAJOR DEPRESSION 5 0.0007
301 INITIAL INSOMNIA 7 0.0007
302 FEELING JITTERY 13 0.0007
303 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
304 ENERGY INCREASED 4 0.0007
305 PRESCRIBED OVERDOSE 13 0.0007
306 HYPERCAPNIA 2 0.0007
307 ADHESION 1 0.0007
308 INCONTINENCE 7 0.0007
309 DRUG EFFECT DELAYED 3 0.0007
310 ASTIGMATISM 1 0.0007
311 AGE-RELATED MACULAR DEGENERATION 1 0.0007
312 MOVEMENT DISORDER 21 0.0007
313 SCOLIOSIS 4 0.0006
314 COORDINATION ABNORMAL 9 0.0006
315 AGGRESSION 32 0.0006
316 SKIN ABRASION 3 0.0006
317 HYPOCALCAEMIA 12 0.0006
318 NON-CARDIAC CHEST PAIN 2 0.0006
319 BLADDER PAIN 2 0.0006
320 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
321 APATHY 9 0.0006
322 BALANCE DISORDER 53 0.0006
323 MICTURITION URGENCY 7 0.0006
324 SEDATION 16 0.0006
325 INJECTION SITE INFECTION 2 0.0006
326 SALIVARY HYPERSECRETION 6 0.0006
327 DRUG TOLERANCE 3 0.0006
328 MYOCLONUS 7 0.0006
329 DEPRESSION 133 0.0006
330 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
331 COGNITIVE DISORDER 27 0.0006
332 CRYING 21 0.0006
333 TACHYPHRENIA 2 0.0006
334 HYPOPNOEA 2 0.0006
335 PANIC ATTACK 21 0.0006
336 HANGOVER 2 0.0006
337 NYSTAGMUS 3 0.0006
338 HYPERHIDROSIS 72 0.0006
339 DEVICE PLACEMENT ISSUE 2 0.0006
340 DRY MOUTH 45 0.0006
341 DEVICE KINK 2 0.0005
342 MUSCULOSKELETAL STIFFNESS 48 0.0005
343 WITHDRAWAL SYNDROME 23 0.0005
344 INTESTINAL ISCHAEMIA 3 0.0005
345 ANOREXIA 7 0.0005
346 PERSONALITY CHANGE 5 0.0005
347 DEMENTIA 15 0.0005
348 ANGER 18 0.0005
349 SPUTUM DISCOLOURED 5 0.0005
350 SOMNOLENCE 106 0.0005
351 HYPERSOMNIA 15 0.0005
352 CLAVICLE FRACTURE 2 0.0005
353 MUSCLE TWITCHING 12 0.0005
354 PNEUMONIA ASPIRATION 13 0.0005
355 FAECES HARD 2 0.0005
356 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
357 AFFECTIVE DISORDER 4 0.0005
358 HOSPICE CARE 5 0.0005
359 HALLUCINATION, AUDITORY 8 0.0005
360 HYPOMAGNESAEMIA 7 0.0005
361 PRESCRIBED UNDERDOSE 10 0.0005
362 DIPLOPIA 13 0.0005
363 SKIN REACTION 7 0.0005
364 MUSCLE DISORDER 4 0.0005
365 HOMICIDAL IDEATION 2 0.0005
366 SUBARACHNOID HAEMORRHAGE 5 0.0005
367 GOITRE 2 0.0005
368 ARTHRITIS BACTERIAL 2 0.0005
369 SELF-MEDICATION 2 0.0005
370 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
371 FEAR 13 0.0005
372 SOCIAL PROBLEM 2 0.0005
373 ILEUS 6 0.0005
374 SUICIDAL BEHAVIOUR 2 0.0005
375 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
376 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
377 SLEEP APNOEA SYNDROME 9 0.0005
378 ANAEMIA MACROCYTIC 1 0.0005
379 SHOULDER OPERATION 2 0.0005
380 GALACTORRHOEA 3 0.0005
381 HIP FRACTURE 15 0.0005
382 ABNORMAL SENSATION IN EYE 2 0.0005
383 TENSION HEADACHE 2 0.0005
384 RESTLESSNESS 17 0.0005
385 APPLICATION SITE SCAB 1 0.0005
386 DELIRIUM 16 0.0005
387 ANXIETY 131 0.0005
388 BIPOLAR DISORDER 5 0.0005
389 NERVOUSNESS 24 0.0005
390 BRADYPHRENIA 3 0.0005
391 PRODUCT PRESCRIBING ISSUE 10 0.0005
392 BLOOD PRESSURE FLUCTUATION 11 0.0005
393 SOMNAMBULISM 3 0.0005
394 DYSPHEMIA 2 0.0005
395 PRODUCT FORMULATION ISSUE 3 0.0005
396 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
397 WHEELCHAIR USER 2 0.0004
398 FALL 149 0.0004
399 ANAL INCONTINENCE 4 0.0004
400 VASCULAR DEVICE INFECTION 2 0.0004
401 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
402 RESTLESS LEGS SYNDROME 8 0.0004
403 DEPRESSED MOOD 23 0.0004
404 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
405 GRAND MAL CONVULSION 4 0.0004
406 MUSCLE TIGHTNESS 7 0.0004
407 MENTAL STATUS CHANGES 12 0.0004
408 FEELING OF DESPAIR 2 0.0004
409 PERFORMANCE STATUS DECREASED 2 0.0004
410 OEDEMA PERIPHERAL 52 0.0004
411 LACERATION 4 0.0004
412 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
413 HAND FRACTURE 3 0.0004
414 ATAXIA 5 0.0004
415 ENDOMETRIOSIS 2 0.0004
416 MACULAR DEGENERATION 5 0.0004
417 PANIC REACTION 3 0.0004
418 APHAGIA 2 0.0004
419 HEAD INJURY 13 0.0004
420 ENCEPHALOPATHY 10 0.0004
421 THROAT TIGHTNESS 11 0.0004
422 PSYCHIATRIC SYMPTOM 3 0.0004
423 BLOOD PRESSURE INCREASED 62 0.0004
424 HYPERCALCAEMIA 5 0.0004
425 FEELING DRUNK 3 0.0004
426 MULTIPLE DRUG OVERDOSE 2 0.0004
427 BODY TEMPERATURE INCREASED 8 0.0004
428 BOWEL MOVEMENT IRREGULARITY 3 0.0004
429 TEMPERATURE INTOLERANCE 4 0.0004
430 TRISMUS 2 0.0004
431 STOMACH DISCOMFORT 2 0.0004
432 WRONG TECHNIQUE IN DRUG USAGE PROCESS 14 0.0004
433 HAEMORRHAGIC STROKE 3 0.0004
434 TREATMENT NONCOMPLIANCE 21 0.0004
435 SPEECH DISORDER 20 0.0004
436 BEDRIDDEN 5 0.0004
437 DYSPHAGIA 36 0.0004
438 LOW BIRTH WEIGHT BABY 3 0.0004
439 BLOOD PRESSURE DECREASED 25 0.0004
440 THINKING ABNORMAL 7 0.0004
441 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
442 ANAESTHETIC COMPLICATION 1 0.0004
443 RHINITIS 3 0.0004
444 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
445 BACK DISORDER 6 0.0004
446 ABDOMINAL RIGIDITY 1 0.0004
447 ANORGASMIA 1 0.0004
448 DECUBITUS ULCER 3 0.0004
449 TACHYPNOEA 5 0.0004
450 IMPAIRED GASTRIC EMPTYING 5 0.0004
451 MOOD ALTERED 10 0.0004
452 POST PROCEDURAL COMPLICATION 7 0.0004
453 SUICIDE ATTEMPT 22 0.0004
454 CHOKING SENSATION 2 0.0004
455 ACUTE CORONARY SYNDROME 3 0.0004
456 DENTAL CARIES 4 0.0004
457 COMPLETED SUICIDE 30 0.0004
458 ORAL DISCOMFORT 5 0.0004
459 MEMORY IMPAIRMENT 49 0.0004
460 SENSATION OF FOREIGN BODY 3 0.0004
461 GAIT DISTURBANCE 68 0.0004
462 DIZZINESS 177 0.0004
463 DYSURIA 13 0.0004
464 HYPOPHAGIA 9 0.0004
465 GENERALISED ERYTHEMA 2 0.0004
466 UPPER LIMB FRACTURE 7 0.0004
467 ERECTILE DYSFUNCTION 9 0.0004
468 VISUAL DISTURBANCE 2 0.0003
469 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
470 ANOSMIA 5 0.0003
471 DEVICE DISLOCATION 15 0.0003
472 DEVICE USE ISSUE 6 0.0003
473 HYPOVOLAEMIA 2 0.0003
474 RIB FRACTURE 7 0.0003
475 SINUS HEADACHE 2 0.0003
476 POLLAKIURIA 14 0.0003
477 CARDIAC PACEMAKER INSERTION 2 0.0003
478 DISTURBANCE IN ATTENTION 18 0.0003
479 THERAPY NON-RESPONDER 15 0.0003
480 ECONOMIC PROBLEM 5 0.0003
481 URINARY RETENTION 11 0.0003
482 SCHIZOPHRENIA 4 0.0003
483 FOETAL GROWTH RESTRICTION 2 0.0003
484 EATING DISORDER 7 0.0003
485 DISORIENTATION 13 0.0003
486 UROSEPSIS 3 0.0003
487 POOR QUALITY SLEEP 7 0.0003
488 SMALL INTESTINAL OBSTRUCTION 4 0.0003
489 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
490 DEVICE ISSUE 29 0.0003
491 EXTRAPYRAMIDAL DISORDER 8 0.0003
492 AGEUSIA 8 0.0003
493 BLOOD SODIUM DECREASED 6 0.0003
494 INFUSION SITE SWELLING 2 0.0003
495 PRODUCT PACKAGING ISSUE 3 0.0003
496 INCREASED APPETITE 6 0.0003
497 MOOD SWINGS 10 0.0003
498 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
499 AFFECT LABILITY 3 0.0003
500 DIZZINESS POSTURAL 3 0.0003
501 INCOHERENT 2 0.0003
502 DYSSTASIA 9 0.0003
503 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
504 COELIAC DISEASE 3 0.0003
505 ACUTE MYOCARDIAL INFARCTION 9 0.0003
506 JOINT STIFFNESS 8 0.0003
507 DYSGRAPHIA 2 0.0003
508 ANXIETY DISORDER 1 0.0003
509 CONDITION AGGRAVATED 91 0.0003
510 HYPOTENSION 60 0.0003
511 QUALITY OF LIFE DECREASED 4 0.0003
512 APHASIA 9 0.0003
513 PRODUCT PHYSICAL ISSUE 6 0.0003
514 PRODUCT LABEL ISSUE 2 0.0003
515 DISEASE RECURRENCE 14 0.0003
516 FEELING ABNORMAL 70 0.0003
517 PALPITATIONS 34 0.0003
518 RESPIRATION ABNORMAL 2 0.0003
519 RHABDOMYOLYSIS 12 0.0003
520 FORMICATION 2 0.0003
521 AORTIC STENOSIS 1 0.0003
522 EXTRASYSTOLES 2 0.0003
523 NECK PAIN 16 0.0003
524 CARPAL TUNNEL SYNDROME 4 0.0003
525 HYPONATRAEMIA 16 0.0003
526 CYSTITIS 9 0.0003
527 FEAR OF INJECTION 2 0.0003
528 APPENDICECTOMY 1 0.0003
529 THIRST 5 0.0003
530 PARALYSIS 4 0.0003
531 UNEVALUABLE EVENT 21 0.0003
532 MENTAL DISORDER 12 0.0003
533 WOUND INFECTION 3 0.0003
534 ORAL DISORDER 2 0.0003
535 DEVICE BREAKAGE 11 0.0003
536 EXPIRED PRODUCT ADMINISTERED 9 0.0003
537 CARDIOMYOPATHY 4 0.0003
538 RASH GENERALISED 7 0.0003
539 GENERAL SYMPTOM 2 0.0003
540 PAROSMIA 2 0.0003
541 MITRAL VALVE INCOMPETENCE 3 0.0003
542 THERAPEUTIC RESPONSE DECREASED 16 0.0003
543 MUSCULOSKELETAL DISORDER 5 0.0003
544 CONVULSION 15 0.0003
545 HYPERTHERMIA 2 0.0003
546 CONSTIPATION 57 0.0003
547 HIP ARTHROPLASTY 4 0.0003
548 DRUG INEFFECTIVE 343 0.0003
549 SYNCOPE 26 0.0003
550 GLAUCOMA 5 0.0003
551 THYROID DISORDER 4 0.0003
552 CONCUSSION 2 0.0003
553 PELVIC FRACTURE 2 0.0003
554 SPINAL PAIN 3 0.0003
555 PRODUCT PRESCRIBING ERROR 6 0.0003
556 RENAL CYST 2 0.0003
557 TRICUSPID VALVE INCOMPETENCE 2 0.0003
558 POLYNEUROPATHY 3 0.0003
559 MOBILITY DECREASED 18 0.0003
560 ADVERSE EVENT 23 0.0002
561 SENSORY LOSS 2 0.0002
562 DRUG EFFECT INCOMPLETE 9 0.0002
563 MENTAL IMPAIRMENT 6 0.0002
564 PRODUCT ADMINISTRATION ERROR 5 0.0002
565 ASPHYXIA 2 0.0002
566 ABNORMAL FAECES 2 0.0002
567 HICCUPS 2 0.0002
568 ANAPHYLACTOID REACTION 1 0.0002
569 ABASIA 6 0.0002
570 GENERALISED OEDEMA 3 0.0002
571 SPINAL COMPRESSION FRACTURE 2 0.0002
572 TOOTH EXTRACTION 3 0.0002
573 SLEEP DISORDER 17 0.0002
574 DRUG ABUSE 20 0.0002
575 COAGULOPATHY 4 0.0002
576 INTENTIONAL PRODUCT MISUSE 21 0.0002
577 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 17 0.0002
578 DERMATITIS ALLERGIC 3 0.0002
579 CELLULITIS 12 0.0002
580 INFUSION SITE ERYTHEMA 2 0.0002
581 TOXICITY TO VARIOUS AGENTS 40 0.0002
582 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 48 0.0002
583 TACHYCARDIA 21 0.0002
584 AORTIC VALVE INCOMPETENCE 1 0.0002
585 ABSCESS LIMB 1 0.0002
586 MYDRIASIS 3 0.0002
587 INTENTIONAL OVERDOSE 15 0.0002
588 MUSCULOSKELETAL DISCOMFORT 4 0.0002
589 MYOPATHY 2 0.0002
590 PRURITUS GENERALISED 5 0.0002
591 MUSCULAR WEAKNESS 26 0.0002
592 HAND DEFORMITY 3 0.0002
593 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
594 BLOOD CALCIUM INCREASED 2 0.0002
595 TOOTH DISORDER 5 0.0002
596 SWOLLEN TONGUE 7 0.0002
597 FACIAL PAIN 2 0.0002
598 MALIGNANT MELANOMA 3 0.0002
599 GASTROINTESTINAL INFECTION 2 0.0002
600 CHROMATURIA 5 0.0002
601 DRUG TOXICITY 3 0.0002
602 ABDOMINAL HERNIA 1 0.0002
603 PERIPHERAL COLDNESS 3 0.0002
604 DEHYDRATION 29 0.0002
605 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
606 DRUG WITHDRAWAL SYNDROME 19 0.0002
607 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
608 HUNGER 3 0.0002
609 DEFORMITY 2 0.0002
610 HEART RATE INCREASED 21 0.0002
611 URINARY TRACT INFECTION 36 0.0002
612 POISONING DELIBERATE 2 0.0002
613 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
614 ACCIDENTAL UNDERDOSE 3 0.0002
615 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
616 PERIPHERAL SWELLING 32 0.0002
617 MUSCLE SPASMS 38 0.0002
618 PHARYNGEAL SWELLING 2 0.0002
619 RENAL TUBULAR NECROSIS 2 0.0002
620 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
621 LIGAMENT SPRAIN 2 0.0002
622 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
623 ABDOMINAL TENDERNESS 1 0.0002
624 RHINORRHOEA 13 0.0002
625 PREGNANCY 4 0.0002
626 HYPERKALAEMIA 7 0.0002
627 HYPERTENSION 42 0.0002
628 INTENTIONAL SELF-INJURY 4 0.0002
629 HYPOTHERMIA 2 0.0002
630 DRY THROAT 2 0.0002
631 WEIGHT INCREASED 44 0.0002
632 SKIN IRRITATION 9 0.0002
633 SKIN DISCOLOURATION 9 0.0002
634 PHARYNGEAL OEDEMA 3 0.0002
635 EAR DISCOMFORT 2 0.0002
636 DRUG RESISTANCE 5 0.0002
637 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
638 VENTRICULAR EXTRASYSTOLES 2 0.0002
639 PETECHIAE 2 0.0002
640 LETHARGY 11 0.0002
641 WEIGHT DECREASED 53 0.0002
642 DECREASED APPETITE 44 0.0002
643 JOINT DISLOCATION 2 0.0002
644 PNEUMOTHORAX 3 0.0002
645 SUDDEN DEATH 2 0.0002
646 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
647 SENSORY DISTURBANCE 3 0.0002
648 SKIN LACERATION 2 0.0002
649 PRODUCT DOSE OMISSION 12 0.0002
650 PRODUCT DISPENSING ERROR 4 0.0002
651 DRUG LEVEL INCREASED 3 0.0002
652 RESPIRATORY DISTRESS 5 0.0002
653 FOOT DEFORMITY 2 0.0002
654 FEELING COLD 5 0.0002
655 LOSS OF CONSCIOUSNESS 23 0.0002
656 PULMONARY OEDEMA 8 0.0002
657 HEADACHE 112 0.0002
658 THROAT IRRITATION 8 0.0002
659 INTESTINAL PERFORATION 2 0.0002
660 OCULAR DISCOMFORT 2 0.0002
661 UNDERDOSE 13 0.0002
662 BLOOD CALCIUM DECREASED 2 0.0002
663 TARDIVE DYSKINESIA 5 0.0002
664 HEART RATE IRREGULAR 4 0.0002
665 REBOUND EFFECT 2 0.0002
666 PAIN IN JAW 5 0.0002
667 IMPAIRED DRIVING ABILITY 2 0.0002
668 INTERNAL HAEMORRHAGE 2 0.0002
669 ANGINA PECTORIS 5 0.0002
670 TINNITUS 8 0.0002
671 SPLENOMEGALY 2 0.0002
672 COLD SWEAT 3 0.0002
673 ASTHENIA 64 0.0002
674 AMNESIA 11 0.0002
675 URINARY INCONTINENCE 5 0.0002
676 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
677 RESPIRATORY DISORDER 5 0.0002
678 HYPOAESTHESIA 25 0.0002
679 C-REACTIVE PROTEIN INCREASED 6 0.0002
680 PRESYNCOPE 4 0.0002
681 NEURALGIA 4 0.0002
682 FEELING HOT 10 0.0002
683 MUSCLE SPASTICITY 2 0.0002
684 SPINAL OPERATION 2 0.0002
685 TENDON RUPTURE 2 0.0002
686 DEVICE LEAKAGE 7 0.0002
687 PHARYNGITIS 2 0.0002
688 CYST 2 0.0002
689 SECRETION DISCHARGE 2 0.0002
690 PHOTOPHOBIA 3 0.0002
691 BRAIN OEDEMA 2 0.0002
692 PRODUCT COMPLAINT 4 0.0002
693 MIGRAINE 15 0.0002
694 CHEST DISCOMFORT 16 0.0002
695 DRUG PRESCRIBING ERROR 3 0.0002
696 UNRESPONSIVE TO STIMULI 4 0.0002
697 HAEMATOMA 4 0.0002
698 NASAL CONGESTION 9 0.0002
699 NEPHROLITHIASIS 7 0.0002
700 CHOLELITHIASIS 5 0.0002
701 ANHEDONIA 4 0.0002
702 GASTRITIS 4 0.0002
703 DISABILITY 3 0.0002
704 FATIGUE 118 0.0002
705 SARS-COV-2 TEST POSITIVE 2 0.0002
706 HAEMATOCRIT DECREASED 3 0.0002
707 BLOOD PRESSURE ABNORMAL 3 0.0002
708 SPINAL FRACTURE 3 0.0001
709 JOINT RANGE OF MOTION DECREASED 2 0.0001
710 NAUSEA 117 0.0001
711 PRODUCT TASTE ABNORMAL 2 0.0001
712 COMA 7 0.0001
713 ABNORMAL LOSS OF WEIGHT 1 0.0001
714 CHEST PAIN 27 0.0001
715 HYPERSENSITIVITY 27 0.0001
716 CONTUSION 14 0.0001
717 RESPIRATORY ARREST 4 0.0001
718 TOOTH LOSS 3 0.0001
719 PROCEDURAL PAIN 4 0.0001
720 PULMONARY HYPERTENSION 3 0.0001
721 ROAD TRAFFIC ACCIDENT 6 0.0001
722 APHONIA 2 0.0001
723 PRODUCT DOSE OMISSION ISSUE 42 0.0001
724 MOUTH ULCERATION 3 0.0001
725 RENAL FAILURE ACUTE 6 0.0001
726 JOINT INJURY 3 0.0001
727 IMPAIRED WORK ABILITY 3 0.0001
728 COUGH 39 0.0001
729 HYPERTHYROIDISM 2 0.0001
730 HYPERGLYCAEMIA 5 0.0001
731 DYSPHONIA 8 0.0001
732 CHILLS 16 0.0001
733 DEVICE DIFFICULT TO USE 9 0.0001
734 RASH MACULO-PAPULAR 3 0.0001
735 MALAISE 59 0.0001
736 CATARACT 8 0.0001
737 GLOSSODYNIA 3 0.0001
738 HAEMORRHAGE 14 0.0001
739 MUSCULOSKELETAL PAIN 7 0.0001
740 ADVERSE DRUG REACTION 12 0.0001
741 HYPOAESTHESIA ORAL 2 0.0001
742 PRODUCT QUALITY ISSUE 18 0.0001
743 LACRIMATION INCREASED 4 0.0001
744 PRODUCT AVAILABILITY ISSUE 3 0.0001
745 VISION BLURRED 18 0.0001
746 DRUG ADMINISTRATION ERROR 4 0.0001
747 EMOTIONAL DISORDER 4 0.0001
748 LIMB DISCOMFORT 4 0.0001
749 FEMUR FRACTURE 4 0.0001
750 EJECTION FRACTION DECREASED 2 0.0001
751 RASH 56 0.0001
752 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
753 BRAIN FOG 2 0.0001
754 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
755 CYANOSIS 2 0.0001
756 PRODUCT USE COMPLAINT 2 0.0001
757 MEDICATION ERROR 7 0.0001
758 RESPIRATORY TRACT CONGESTION 2 0.0001
759 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
760 METABOLIC ACIDOSIS 4 0.0001
761 DRUG INTOLERANCE 12 0.0001
762 NIGHT SWEATS 4 0.0001
763 RESPIRATORY FAILURE 9 0.0001
764 INCORRECT DOSE ADMINISTERED 28 0.0001
765 PRODUCT USE ISSUE 23 0.0001
766 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
767 PARAESTHESIA 19 0.0001
768 BACK PAIN 28 0.0001
769 LIP SWELLING 4 0.0001
770 CARDIO-RESPIRATORY ARREST 5 0.0001
771 BLOOD UREA INCREASED 2 0.0001
772 URTICARIA 20 0.0001
773 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
774 MYALGIA 20 0.0001
775 ACUTE KIDNEY INJURY 18 0.0001
776 CIRCULATORY COLLAPSE 2 0.0001
777 SCAR 2 0.0001
778 ERYTHEMA 24 0.0001
779 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
780 ABDOMINAL PAIN 27 0.0001
781 OVERDOSE 25 0.0001
782 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
783 DEVICE DEFECTIVE 2 0.0001
784 DEVICE USE ERROR 4 0.0001
785 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
786 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
787 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
788 HOSPITALISATION 17 0.0001
789 LEUKOCYTOSIS 2 0.0001
790 TOOTHACHE 2 0.0001
791 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
792 JOINT SWELLING 13 0.0001
793 AGRANULOCYTOSIS 2 0.0001
794 HEPATIC STEATOSIS 2 0.0001
795 APPENDICITIS 1 0.0001
796 ABDOMINAL PAIN UPPER 22 0.0001
797 ARTERIOSCLEROSIS 1 0.0001
798 ABORTION INDUCED 1 0.0001
799 INTESTINAL OBSTRUCTION 4 0.0001
800 FLATULENCE 6 0.0001
801 BLOOD URINE PRESENT 2 0.0001
802 PROTEINURIA 2 0.0001
803 PRODUCT SUBSTITUTION ISSUE 6 0.0001
804 ATELECTASIS 1 0.0001
805 HERNIA 2 0.0001
806 LIVER FUNCTION TEST ABNORMAL 3 0.0001
807 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
808 KIDNEY INFECTION 2 0.0001
809 WHEEZING 6 0.0001
810 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
811 SINUS DISORDER 2 0.0001
812 GASTROINTESTINAL DISORDER 9 0.0001
813 INJURY 7 0.0001
814 HEPATIC FAILURE 3 0.0001
815 EMOTIONAL DISTRESS 12 0.0001
816 CORONARY ARTERY DISEASE 3 0.0001
817 ILL-DEFINED DISORDER 6 0.0001
818 VERTIGO 6 0.0001
819 EPILEPSY 3 0.0001
820 THERAPY CESSATION 5 0.0001
821 INFLUENZA LIKE ILLNESS 8 0.0001
822 OFF LABEL USE 85 0.0001
823 ILLNESS 10 0.0001
824 PNEUMONIA 31 0.0001
825 INTENTIONAL DRUG MISUSE 2 0.0001
826 DYSPNOEA 54 0.0001
827 RENAL IMPAIRMENT 8 0.0001
828 CEREBROVASCULAR ACCIDENT 16 0.0001
829 OSTEOARTHRITIS 4 0.0001
830 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
831 DEATH 81 0.0001
832 RECTAL HAEMORRHAGE 4 0.0001
833 FAECES DISCOLOURED 2 0.0001
834 OEDEMA 5 0.0001
835 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
836 ASPIRATION 1 0.0001
837 VISUAL ACUITY REDUCED 3 0.0001
838 ABDOMINAL DISCOMFORT 15 0.0001
839 ORAL PAIN 2 0.0001
840 SNEEZING 2 0.0001
841 EYE IRRITATION 5 0.0001
842 SEIZURE 10 0.0001
843 PERICARDIAL EFFUSION 2 0.0001
844 RASH MACULAR 3 0.0001
845 PAIN IN EXTREMITY 25 0.0001
846 CARDIAC ARREST 7 0.0001
847 PAIN 52 0.0001
848 CEREBRAL HAEMORRHAGE 3 0.0001
849 PRURITUS 32 0.0001
850 LOCALISED INFECTION 2 0.0001
851 ACCIDENTAL OVERDOSE 3 0.0001
852 CEREBRAL INFARCTION 2 0.0001
853 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
854 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
855 DRY EYE 4 0.0001
856 HAEMATEMESIS 2 0.0001
857 HEPATITIS 2 0.0001
858 SWELLING FACE 5 0.0001
859 ABDOMINAL DISTENSION 8 0.0001
860 DEAFNESS 2 0.0001
861 ARTHRITIS 6 0.0001
862 ADVERSE REACTION 1 0.0001
863 EAR INFECTION 2 0.0001
864 SWELLING 7 0.0001
865 CARDIAC FAILURE 6 0.0001
866 THROMBOSIS 6 0.0001
867 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
868 VOMITING 35 0.0001
869 BLINDNESS 3 0.0001
870 NEUROPATHY PERIPHERAL 7 0.0001
871 SKIN LESION 2 0.0001
872 HAEMOPTYSIS 2 0.0001
873 WOUND 2 0.0001
874 BLISTER 4 0.0001
875 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
876 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
877 INTENTIONAL DOSE OMISSION 2 0.0001
878 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
879 THERAPY INTERRUPTED 5 0.0001
880 RED BLOOD CELL COUNT DECREASED 2 0.0001
881 HYPOACUSIS 3 0.0001
882 MYOCARDIAL INFARCTION 12 0.0001
883 SURGERY 4 0.0001
884 DYSGEUSIA 5 0.0001
885 BLOOD POTASSIUM DECREASED 2 0.0001
886 PREMATURE BABY 2 0.0001
887 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
888 PLEURAL EFFUSION 4 0.0001
889 DISCOMFORT 4 0.0001
890 HYPOKALAEMIA 3 0.0001
891 ARTHRALGIA 27 0.0001
892 OROPHARYNGEAL PAIN 6 0.0001
893 ANKLE FRACTURE 1 0.0001
894 CARDIAC DISORDER 6 0.0001
895 NERVOUS SYSTEM DISORDER 2 0.0001
896 PRODUCTIVE COUGH 3 0.0001
897 SEPSIS 7 0.0001
898 BLOOD GLUCOSE DECREASED 3 0.0001
899 INFECTION 9 0.0001
900 ATRIAL FIBRILLATION 6 0.0001
901 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
902 BLOOD CREATININE INCREASED 4 0.0001
903 ALOPECIA 12 0.0001
904 DYSPEPSIA 6 0.0001
905 EYE DISORDER 2 0.0001
906 STAPHYLOCOCCAL INFECTION 2 0.0001
907 INFUSION RELATED REACTION 4 0.0001
908 VIRAL INFECTION 2 0.0001
909 SKIN DISORDER 2 0.0001
910 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
911 TYPE 2 DIABETES MELLITUS 2 0.0001
912 FLUID RETENTION 3 0.0001
913 SINUSITIS 6 0.0001
914 HAEMATURIA 2 0.0001
915 GASTRIC DISORDER 2 0.0001
916 INJECTION SITE REACTION 4 0.0001
917 PRODUCT STORAGE ERROR 5 0.0001
918 AMENORRHOEA 1 0.0001
919 HEART RATE DECREASED 2 0.0001
920 HYPOXIA 2 0.0001
921 BRADYCARDIA 3 0.0001
922 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
923 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
924 NO ADVERSE EVENT 10 0.0001
925 DRUG DOSE OMISSION 9 0.0001
926 ANAPHYLACTIC REACTION 3 0.0001
927 NASOPHARYNGITIS 10 0.0001
928 BRONCHITIS 4 0.0001
929 DYSPNOEA EXERTIONAL 2 0.0001
930 RENAL FAILURE 7 0.0001
931 PULMONARY EMBOLISM 5 0.0001
932 HERPES ZOSTER 3 0.0001
933 ACUTE RESPIRATORY FAILURE 1 0.0001
934 BONE PAIN 3 0.0001
935 DISEASE PROGRESSION 6 0.0001
936 STOMATITIS 3 0.0000
937 PSORIATIC ARTHROPATHY 2 0.0000
938 PYREXIA 17 0.0000
939 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
940 HAEMOGLOBIN DECREASED 5 0.0000
941 DEEP VEIN THROMBOSIS 3 0.0000
942 SEPTIC SHOCK 2 0.0000
943 ANGIOEDEMA 2 0.0000
944 LIVER DISORDER 2 0.0000
945 DIARRHOEA 29 0.0000
946 INFLUENZA 5 0.0000
947 ASTHMA 5 0.0000
948 DRUG DEPENDENCE 7 0.0000
949 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
950 RENAL DISORDER 2 0.0000
951 BURNING SENSATION 3 0.0000
952 ARRHYTHMIA 2 0.0000
953 OCULAR HYPERAEMIA 2 0.0000
954 SKIN BURNING SENSATION 3 0.0000
955 HYPOGLYCAEMIA 2 0.0000
956 LUNG DISORDER 2 0.0000
957 VISUAL IMPAIRMENT 5 0.0000
958 EPISTAXIS 3 0.0000
959 HOT FLUSH 3 0.0000
960 ABDOMINAL PAIN LOWER 1 0.0000
961 DIABETES MELLITUS 3 0.0000
962 FLUSHING 4 0.0000
963 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
964 ECZEMA 2 0.0000
965 PANCREATITIS 2 0.0000
966 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
967 PLATELET COUNT DECREASED 4 0.0000
968 CARDIAC FAILURE CONGESTIVE 3 0.0000
969 PROSTATE CANCER 3 0.0000
970 RASH PRURITIC 2 0.0000
971 HAEMATOCHEZIA 2 0.0000
972 TREATMENT FAILURE 3 0.0000
973 ARTHROPATHY 2 0.0000
974 OXYGEN SATURATION DECREASED 2 0.0000
975 SKIN EXFOLIATION 3 0.0000
976 ASCITES 1 0.0000
977 INJECTION SITE PAIN 10 0.0000
978 INJECTION SITE ERYTHEMA 4 0.0000
979 EXPOSURE DURING PREGNANCY 2 0.0000
980 ANAEMIA 6 0.0000
981 PSORIASIS 4 0.0000
982 COVID-19 5 0.0000
983 THROMBOCYTOPENIA 3 0.0000
984 BLOOD GLUCOSE INCREASED 5 0.0000
985 INJECTION SITE SWELLING 2 0.0000
986 INJECTION SITE HAEMORRHAGE 2 0.0000
987 DRY SKIN 3 0.0000
988 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
989 RHEUMATOID ARTHRITIS 2 0.0000
990 ACNE 1 0.0000
991 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000